Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Editorial: Special issue on rare cancers.

Literature DB >> 34304884

Editorial: Special issue on rare cancers.

Abby Sandler¹, Karlyne Reilly², Brigitte Widemann³.

Abstract

Entities: Chemical

Mesh：

Year: 2021 PMID： 34304884 PMCID： PMC8383746 DOI： 10.1016/j.currproblcancer.2021.100774

Source DB: PubMed Journal: Curr Probl Cancer ISSN： 0147-0272 Impact factor: 3.187

Keyword Cloud
References

× No keyword cloud information.

8 in total

1. The occurrence of rare cancers in U.S. adults, 1995-2004.

Authors: Robert T Greenlee; Marc T Goodman; Charles F Lynch; Charles E Platz; Lori A Havener; Holly L Howe
Journal: Public Health Rep Date: 2010 Jan-Feb Impact factor: 2.792

2. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

Authors: Gemma Gatta; Riccardo Capocaccia; Laura Botta; Sandra Mallone; Roberta De Angelis; Eva Ardanaz; Harry Comber; Nadya Dimitrova; Maarit K Leinonen; Sabine Siesling; Jan M van der Zwan; Liesbet Van Eycken; Otto Visser; Maja P Žakelj; Lesley A Anderson; Francesca Bella; Innos Kaire; Renée Otter; Charles A Stiller; Annalisa Trama
Journal: Lancet Oncol Date: 2017-07-04 Impact factor: 41.316

Editorial: Special issue on rare cancers.

1. The occurrence of rare cancers in U.S. adults, 1995-2004.

2. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

3. The burden of rare cancers in the United States.

Review 4. A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.

5. Mutation and cancer: statistical study of retinoblastoma.

Review 6. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.

Review 7. NTRK fusion-positive cancers and TRK inhibitor therapy.

8. International Rare Cancers Initiative (IRCI).